Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteobrix-CT
- Development stage
- Unknown
- Lead developer
- Stevia Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Osteobrix-CT is a combination pharmaceutical product developed by Stevia Pharmaceuticals, primarily indicated for the management of bone health and calcium deficiency. It is formulated as an oral tablet containing calcitriol, calcium carbonate, and zinc. Calcitriol, the active form of vitamin D3, acts as an agonist at the vitamin D receptor (VDR) to enhance intestinal calcium absorption and regulate bone mineralization. Calcium carbonate provides a concentrated source of elemental calcium, while zinc serves as an essential mineral cofactor for enzymes involved in bone matrix synthesis and osteoblastic activity. Osteobrix-CT is used to treat or prevent conditions such as osteoporosis, osteomalacia, and hypocalcemia.
- Brand names
- Osteobrix-CT
- Other names
- Osteobrix-CT Tablets
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Osteobrix-CT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osteobrix-CT.